Figure 5
From: Transforming growth factor-β suppresses metastasis in a subset of human colon carcinoma cells
Determination of the status of molecular markers in vivo . (A) Immunohistochemical staining of pAKT-S473 performed on FETα and FETα-DN primary tumors. To confirm antibody specificity, a blocking peptide was used. (B) Immunohistochemical staining of XIAP protein performed on FETα and FETα-DN primary tumors. To confirm antibody specificity, a blocking peptide was used.